Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Donadieu

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
British Journal of Haematology|April 27, 2017
Circulating cell-free BRAF<sup>V600E</sup> as a biomarker in children with Langerhans cell histiocytosisSébastien Héritier, Zofia Hélias-Rodzewicz, Hélène Lapillonne, et al.
Blood|June 2, 2019
EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndromeShengjiang Tan, Laëtitia Kermasson, Angela Hoslin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 2026
ALKATI drives nuclear ALK expression in histiocytic neoplasms without ALK fusionsZofia Hélias-Rodzewicz, Irena Antonia Ungureanu, Paul Geraeds Kemps, et al.
British Journal of Haematology|April 6, 2026
Neurofilament as a biomarker of neurodegeneration in childhood Langerhans cell histiocytosis: A feasibility study on 273 patientsSolenne Le Louet, Camille Brunaud, Mohamed Barkaoui, et al.
International Journal of Cancer|March 27, 2020
PTPN11 mutations in canine and human disseminated histiocytic sarcomaBenoit Hédan, Mélanie Rault, Jérôme Abadie, et al.
Blood|June 5, 2014
Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutationBaptiste Hervier, Julien Haroche, Laurent Arnaud, et al.
Blood|August 12, 2015
Severe chronic primary neutropenia in adults: report on a series of 108 patientsFlore Sicre de Fontbrune, Aline Moignet, Blandine Beaupain, et al.
British Journal of Haematology|June 9, 2016
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of ageCharlotte Rigaud, Mohamed A Barkaoui, Caroline Thomas, et al.
Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.
Haematologica|February 2, 2023
Somatic genetic alterations predict hematological progression in GATA2 deficiencyLaetitia Largeaud, Matthew Collin, Nils Monselet, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
British Journal of Haematology|April 27, 2017
Circulating cell-free BRAF<sup>V600E</sup> as a biomarker in children with Langerhans cell histiocytosisSébastien Héritier, Zofia Hélias-Rodzewicz, Hélène Lapillonne, et al.
Blood|June 2, 2019
EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndromeShengjiang Tan, Laëtitia Kermasson, Angela Hoslin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 2026
ALKATI drives nuclear ALK expression in histiocytic neoplasms without ALK fusionsZofia Hélias-Rodzewicz, Irena Antonia Ungureanu, Paul Geraeds Kemps, et al.
British Journal of Haematology|April 6, 2026
Neurofilament as a biomarker of neurodegeneration in childhood Langerhans cell histiocytosis: A feasibility study on 273 patientsSolenne Le Louet, Camille Brunaud, Mohamed Barkaoui, et al.
International Journal of Cancer|March 27, 2020
PTPN11 mutations in canine and human disseminated histiocytic sarcomaBenoit Hédan, Mélanie Rault, Jérôme Abadie, et al.
Blood|June 5, 2014
Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutationBaptiste Hervier, Julien Haroche, Laurent Arnaud, et al.
Blood|August 12, 2015
Severe chronic primary neutropenia in adults: report on a series of 108 patientsFlore Sicre de Fontbrune, Aline Moignet, Blandine Beaupain, et al.
British Journal of Haematology|June 9, 2016
Langerhans cell histiocytosis: therapeutic strategy and outcome in a 30-year nationwide cohort of 1478 patients under 18 years of ageCharlotte Rigaud, Mohamed A Barkaoui, Caroline Thomas, et al.
Blood|August 24, 2014
Recurrent RAS and PIK3CA mutations in Erdheim-Chester diseaseJean-François Emile, Eli L Diamond, Zofia Hélias-Rodzewicz, et al.
Haematologica|February 2, 2023
Somatic genetic alterations predict hematological progression in GATA2 deficiencyLaetitia Largeaud, Matthew Collin, Nils Monselet, et al.
Pageof 18